by Rachel Montague | Jun 15, 2020 | Industry insights
Written by Tom Macmillan, Consultant – Systematic Review The NICE Medical Technologies Evaluation Programme (MTEP) evaluates novel medical devices and diagnostics for use within the National Health Service (NHS). There are currently 3 outputs from the...
by Rachel Montague | Nov 2, 2019 | Industry insights
Written by Chris Hellmund (Senior Medical Writer) and Neil Webb (Head of Systematic Review) A poster on this topic was presented at ISPOR Europe 2019. This blog post provides an overview of our findings.The abstract is available here. In previous blog posts, we...
by Mark | Oct 22, 2019 | Industry insights
Written by Julie Fricke (Systematic Review Analyst) and Neil Webb (Head of Systematic Review) Systematic Reviews – The Problem Although considered the gold standard of quality research, systematic literature reviews (SLRs) are very resource intensive (e.g. long...
by Rachel Montague | Oct 2, 2019 | Industry insights
Written by Chris Hellmund, Senior Medical Writer In a previous post, we discussed the origins of the NICE Highly Specialised Technologies (HST) process for the evaluation of therapies for rare diseases. In this blog, we examine the key differences between the Single...
by Rachel Montague | Jun 2, 2019 | Industry insights
Written by Chris Hellmund, Senior Medical Writer Origins of the Highly Specialised Technologies (HST) process Treatments for very rare conditions represent a unique challenge to payers. Extremely low patient numbers mean that often only Phase 1/2 trial data are...
by Rachel Montague | May 2, 2019 | Industry insights
Written by Neil Webb (Head of Systematic Review) and Chris Hellmund (Senior Medical Writer) On the 1st April 2017, the National Institute for Health and Care Excellence (NICE) introduced a fast-track appraisal (FTA) process, with the aim of providing quicker access...
